Compare CART & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CART | TECH |
|---|---|---|
| Founded | 2012 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.6B |
| IPO Year | 2023 | 1995 |
| Metric | CART | TECH |
|---|---|---|
| Price | $39.66 | $50.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 11 |
| Target Price | $52.24 | ★ $71.82 |
| AVG Volume (30 Days) | ★ 4.4M | 3.3M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | ★ 1.27 | N/A |
| EPS | 0.57 | ★ 0.81 |
| Revenue | ★ $3,742,000,000.00 | $1,219,635,000.00 |
| Revenue This Year | $13.44 | $2.49 |
| Revenue Next Year | $9.71 | $6.40 |
| P/E Ratio | $71.47 | ★ $61.44 |
| Revenue Growth | ★ 10.78 | 5.23 |
| 52 Week Low | $32.73 | $43.20 |
| 52 Week High | $53.50 | $72.16 |
| Indicator | CART | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 51.01 |
| Support Level | $37.81 | $49.98 |
| Resistance Level | $40.31 | $57.86 |
| Average True Range (ATR) | 1.70 | 1.87 |
| MACD | -0.05 | 0.71 |
| Stochastic Oscillator | 26.77 | 79.17 |
Maplebear (Instacart) is a grocery-focused delivery marketplace that connects national and regional grocers with consumers and couriers, and consumers with their favorite stores. Its app provides on-demand convenience for consumers, allows couriers to earn income, and helps grocers to scale their business through digital channels. The marketplace gathers valuable consumer behavior data, attracting consumer-packaged-goods advertisers that seek to reach consumers at the point of purchase. With approximately 600,000 shoppers and 1,800 retail partners, Instacart delivers to about 98% of households in the United States and Canada.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.